Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor Added to G-CSF for Stem Cell Mobilization in Poor Mobilizers
NCT00396331Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2005
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in lymphoma, multiple myeloma (MM), sponsored by Sanofi. Started Oct 2005; status: completed.
02
Drugs
plerixafor
03
Conditions
lymphomamultiple myeloma (MM)
Beyond the preview
Go deeper on NCT00396331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396331.